FOR
IMMEDIATE RELEASE
4Life
Research™ Awarded Exclusive Patent
for Egg-Derived Transfer Factor
S
A N D Y, U TAH
October 22, 2002—4Life Research™, LC announced
today it has been awarded the exclusive patent (US Patent #
6,468,534)
for extracting
transfer factors from the eggs of nonmammalian
sources. “This original patent
protects 4Life’s continued exclusivity in the transfer factor
market and secures its opportunity for expanded research and
development with transfer factors and immune health,” said Chief
Scientific Officer at 4Life Research™, William Hennen, Ph.D.
U.S.Patent Office-View
Patent
Transfer
Factors are a scientifically recognized delivery system for
transferring immune system advantages from one species to another.
In the patented process owned by 4Life™, these tiny molecules
are extracted from eggs and then transferred to humans in the
form of a nutritional supplement.
4Life
Research has already established itself as the recognized leader
of Transfer Factor™ products, with products for adults, children,
and even animals. In addition to its revolutionary products,
Transfer Factor™ and Transfer Factor Plus™, 4Life™ recently
released a new product, TF Cardio™, to provide targeted Transfer
Factor support for the entire cardiovascular system. 4Life™
also uses a patent for extracting Transfer Factors from bovine
colostrum (US Patent # 4,816,563).
4Life™
currently operates in the United States, Japan, New Zealand
and Australia, with several other international markets opening
soon. According to David Lisonbee, Chief Executive Officer of
4Life Research, “This historical announcement further cements
4Life's growing presence in the dietary supplement marketplace,
both domestically and internationally. We’re excited to continue
developing innovative and effective immune-enhancing products
with this remarkable molecule, Transfer Factor.


If you have any questions or need assistance with ordering
online or by phone, we are pleased to help!!